CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Novartis - CHF - NOVN CFD

    91.60
    0.97%
    0.40
    Low: 91.55
    High: 92.15
    Market Trading Hours* (UTC) Opens on Monday at 07:00

    Mon - Fri: 07:00 - 15:20

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.40
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.015699 %
    Charges from full value of position ($-2.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.015699%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.006523 %
    Charges from full value of position ($-1.24)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.006523%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency CHF
    Margin 5%
    Stock exchange Switzerland
    Commission on trade 0%

    *Information provided by Capital.com

    Novartis AG ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 92.5
    Open* 91.85
    1-Year Change* 21.66%
    Day's Range* 91.55 - 92.15
    52 wk Range 73.32-93.95
    Average Volume (10 days) 2.27M
    Average Volume (3 months) 55.31M
    Market Cap 202.26B
    P/E Ratio 27.73
    Shares Outstanding 2.07B
    Revenue 47.30B
    EPS 3.20
    Dividend (Yield %) 3.61052
    Beta 0.96
    Next Earnings Date Oct 24, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Sep 22, 2023 91.60 0.00 0.00% 91.60 92.20 91.25
    Sep 21, 2023 92.50 -0.20 -0.22% 92.70 93.80 92.10
    Sep 20, 2023 92.75 0.20 0.22% 92.55 93.20 91.95
    Sep 19, 2023 91.60 0.65 0.71% 90.95 92.15 90.45
    Sep 18, 2023 91.70 0.05 0.05% 91.65 92.40 91.25
    Sep 15, 2023 92.05 0.55 0.60% 91.50 92.75 90.65
    Sep 14, 2023 90.15 0.35 0.39% 89.80 91.10 89.65
    Sep 13, 2023 89.15 -0.15 -0.17% 89.30 89.95 88.40
    Sep 12, 2023 88.95 0.85 0.96% 88.10 90.05 88.10
    Sep 11, 2023 88.20 0.55 0.63% 87.65 88.45 87.35
    Sep 8, 2023 87.95 0.10 0.11% 87.85 88.30 87.35
    Sep 7, 2023 88.25 1.60 1.85% 86.65 88.40 86.65
    Sep 6, 2023 87.00 -0.05 -0.06% 87.05 87.05 85.85
    Sep 5, 2023 87.75 -0.65 -0.74% 88.40 88.90 87.25
    Sep 4, 2023 88.80 -0.25 -0.28% 89.05 89.60 88.20
    Sep 1, 2023 89.10 0.15 0.17% 88.95 89.35 88.40
    Aug 31, 2023 87.85 -1.80 -2.01% 89.65 89.75 87.85
    Aug 30, 2023 89.90 -0.55 -0.61% 90.45 90.45 89.60
    Aug 29, 2023 90.20 -0.25 -0.28% 90.45 90.75 89.50
    Aug 28, 2023 90.35 0.75 0.84% 89.60 91.15 89.60

    Novartis - CHF Events

    Time (UTC) Country Event
    Tuesday, October 24, 2023

    Time (UTC)

    06:30

    Country

    CH

    Event

    Q3 2023 Novartis AG Earnings Release
    Q3 2023 Novartis AG Earnings Release

    Forecast

    -

    Previous

    -
    Monday, November 13, 2023

    Time (UTC)

    10:59

    Country

    CH

    Event

    Novartis AG Impact & Sustainability Annual Event
    Novartis AG Impact & Sustainability Annual Event

    Forecast

    -

    Previous

    -
    Wednesday, November 15, 2023

    Time (UTC)

    10:59

    Country

    CH

    Event

    Novartis AG at UBS European Conference
    Novartis AG at UBS European Conference

    Forecast

    -

    Previous

    -

    Time (UTC)

    10:59

    Country

    CH

    Event

    Novartis AG at Wolfe Research Healthcare Conference
    Novartis AG at Wolfe Research Healthcare Conference

    Forecast

    -

    Previous

    -
    Tuesday, November 28, 2023

    Time (UTC)

    10:59

    Country

    CH

    Event

    Novartis AG R&D Day
    Novartis AG R&D Day

    Forecast

    -

    Previous

    -
    Wednesday, March 6, 2024

    Time (UTC)

    09:00

    Country

    CH

    Event

    Novartis AG Annual Shareholders Meeting
    Novartis AG Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 51742 52877 49898 48624 46017
    Revenue 51742 52877 49898 48624 46017
    Cost of Revenue, Total 14998 15435 14400 13930 13555
    Gross Profit 36744 37442 35498 34694 32462
    Total Operating Expense 42545 41188 39746 39538 31824
    Selling/General/Admin. Expenses, Total 14190 14815 14093 14319 13690
    Research & Development 9088 9041 8484 8386 8154
    Depreciation / Amortization 158 109 64 50 179
    Unusual Expense (Income) 3402 1173 2503 2284 -4309
    Other Operating Expenses, Total 449 653 538 607 549
    Operating Income 9197 11689 10152 9086 14193
    Interest Income (Expense), Net Non-Operating -543 14628 -146 -36 -5
    Other, Net -283 -180 -128 -110 -93
    Net Income Before Taxes 8371 26137 9878 8940 14095
    Net Income After Taxes 6955 24018 8071 7147 12800
    Minority Interest 0 3 1 -5 -3
    Net Income Before Extra. Items 6955 24021 8072 7142 12797
    Net Income 6955 24021 8072 11732 12611
    Income Available to Common Excl. Extra. Items 6955 24021 8072 7142 12797
    Income Available to Common Incl. Extra. Items 6955 24021 8072 11732 12611
    Dilution Adjustment
    Diluted Net Income 6955 24021 8072 11732 12611
    Diluted Weighted Average Shares 2197 2260 2296 2319 2344
    Diluted EPS Excluding Extraordinary Items 3.16568 10.6288 3.51568 3.07978 5.45947
    Dividends per Share - Common Stock Primary Issue 3.46171 3.19907 3.38945 3.04815 2.90402
    Diluted Normalized EPS 4.47075 11.1183 4.40641 3.86715 3.79006
    Total Extraordinary Items 4590 -186
    Interest Expense (Income) - Net Operating 260 -38 -336 -38 6
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 13936 13208 13001 12842 13085
    Revenue 13936 13208 13001 12842 13085
    Cost of Revenue, Total 4006 3829 3837 3657 3749
    Gross Profit 9930 9379 9164 9185 9336
    Total Operating Expense 11016 10352 11052 10674 10857
    Selling/General/Admin. Expenses, Total 3673 3401 3699 3404 3589
    Research & Development 2349 2272 2318 2263 2251
    Depreciation / Amortization 45 153 42 42 39
    Interest Expense (Income) - Net Operating 29 46 -28 90 96
    Unusual Expense (Income) 858 298 1145 1068 996
    Other Operating Expenses, Total 56 353 39 150 137
    Operating Income 2920 2856 1949 2168 2228
    Interest Income (Expense), Net Non-Operating -226 -212 -222 -219 -202
    Other, Net 75 96 14 -30 16
    Net Income Before Taxes 2769 2740 1741 1919 2042
    Net Income After Taxes 2317 2294 1466 1575 1695
    Minority Interest -1 -1 0 -2 -1
    Net Income Before Extra. Items 2316 2293 1466 1573 1694
    Net Income 2316 2293 1466 1573 1694
    Income Available to Common Excl. Extra. Items 2316 2293 1466 1573 1694
    Income Available to Common Incl. Extra. Items 2316 2293 1466 1573 1694
    Diluted Net Income 2316 2293 1466 1573 1694
    Diluted Weighted Average Shares 2095 2120 2158 2180 2211
    Diluted EPS Excluding Extraordinary Items 1.10549 1.0816 0.67933 0.72156 0.76617
    Dividends per Share - Common Stock Primary Issue 0 0 3.46171 0 0
    Diluted Normalized EPS 1.45098 1.20956 1.14055 1.12553 1.14122
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 36910 45718 29673 29504 35563
    Cash and Short Term Investments 18726 28113 11293 11234 15718
    Cash 2877 3396 3750 3247 3121
    Cash & Equivalents 4640 9011 5908 7865 10150
    Short Term Investments 11209 15706 1635 122 2447
    Total Receivables, Net 9894 9621 10036 10337 11036
    Accounts Receivable - Trade, Net 8066 8005 8217 8301 8739
    Total Inventory 7175 6666 7131 5982 6956
    Prepaid Expenses 911 1102 943 898 812
    Other Current Assets, Total 204 216 270 1053 1041
    Total Assets 117453 131795 127778 118370 145563
    Property/Plant/Equipment, Total - Net 12195 13106 13939 13746 15696
    Property/Plant/Equipment, Total - Gross 26304 28708 29894 28676 34028
    Accumulated Depreciation, Total -14109 -15602 -15955 -14930 -18332
    Goodwill, Net 29301 29595 29999 26524 35294
    Intangibles, Net 31644 34182 36809 28787 38719
    Long Term Investments 1606 2268 11611 10538 9789
    Note Receivable - Long Term 948 973 922 624 908
    Other Long Term Assets, Total 4849 5953 4825 8647 9594
    Total Current Liabilities 28656 30208 33059 28264 29607
    Accounts Payable 5146 5553 5403 5424 5556
    Accrued Expenses 5334 5100 5336 5058 5105
    Notes Payable/Short Term Debt 3635 3606 7319 4844 6430
    Current Port. of LT Debt/Capital Leases 2492 2896 2558 2248 3190
    Other Current Liabilities, Total 12049 13053 12443 10690 9326
    Total Liabilities 58111 64140 71180 62896 66949
    Total Long Term Debt 21782 24523 27978 22056 22470
    Long Term Debt 20244 22902 26259 20353 22470
    Deferred Income Tax 2686 3070 3141 5867 7475
    Minority Interest 81 167 68 77 78
    Other Liabilities, Total 4906 6172 6934 6632 7319
    Total Equity 59342 67655 56598 55474 78614
    Common Stock 890 901 913 936 944
    Retained Earnings (Accumulated Deficit) 63540 70989 57157 59274 82191
    Treasury Stock - Common -92 -48 -53 -80 -69
    Unrealized Gain (Loss) -198 206
    Other Equity, Total -4798 -4187 -1419 -4656 -4658
    Total Liabilities & Shareholders’ Equity 117453 131795 127778 118370 145563
    Total Common Shares Outstanding 2119.61 2234.94 2256.82 2265.01 2311.17
    Capital Lease Obligations 1538 1621 1719 1703
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total Current Assets 32114 36910 36954 38142 37236
    Cash and Short Term Investments 12260 18930 19103 19758 18814
    Cash & Equivalents 12000 7517 8726 3625 13852
    Short Term Investments 260 11413 10377 16133 4962
    Total Receivables, Net 9183 8334 8680 8910 8678
    Accounts Receivable - Trade, Net 8916 8066 8422 8643 8409
    Total Inventory 7886 7175 6779 6880 6997
    Other Current Assets, Total 2785 2471 2392 2594 2747
    Total Assets 112241 117453 118464 122910 125218
    Property/Plant/Equipment, Total - Net 12348 12195 11731 12206 12861
    Goodwill, Net 29481 29301 28668 29113 29636
    Intangibles, Net 30451 31644 31888 33367 34853
    Long Term Investments 2555 2554 2491 2580 2906
    Other Long Term Assets, Total 5292 4849 6732 7502 7726
    Total Current Liabilities 30549 28656 28160 27646 29807
    Accounts Payable 5426 5146 4693 4969 5083
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 7166 6127 7204 7247 6902
    Other Current Liabilities, Total 17957 17383 16263 15430 17822
    Total Liabilities 60182 58111 57644 59985 63678
    Total Long Term Debt 21985 21782 21235 23784 24373
    Long Term Debt 20396 20244 19732 22232 22796
    Capital Lease Obligations 1589 1538 1503 1552 1577
    Deferred Income Tax 2727 2686 2719 3122 3384
    Minority Interest 83 81 78 81 164
    Other Liabilities, Total 4838 4906 5452 5352 5950
    Total Equity 52059 59342 60820 62925 61540
    Common Stock 842 890 890 890 901
    Retained Earnings (Accumulated Deficit) 51253 58544 60000 62095 60699
    Treasury Stock - Common -36 -92 -70 -60 -60
    Total Liabilities & Shareholders’ Equity 112241 117453 118464 122910 125218
    Total Common Shares Outstanding 2097.4 2119.61 2150.98 2182.79 2212.58
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 6955 24018 8071 7147 12800
    Cash From Operating Activities 14236 15071 13650 13625 14272
    Cash From Operating Activities 1873 1807 2088 1852 1783
    Amortization 5308 4306 4376 3974 3428
    Non-Cash Items 4404 -11714 3842 3369 -2315
    Cash Taxes Paid 1975 2342 1833 1876 1506
    Cash Interest Paid 696 664 703 793 816
    Changes in Working Capital -4304 -3346 -4727 -2717 -1424
    Cash From Investing Activities 1468 4208 -13182 -2226 -5591
    Capital Expenditures -2671 -2971 -2585 -2257 -2648
    Other Investing Cash Flow Items, Total 4139 7179 -10597 31 -2943
    Cash From Financing Activities -20562 -16264 -2208 -13627 -4244
    Financing Cash Flow Items 55 94 -199 3307 -119
    Total Cash Dividends Paid -7506 -7368 -6987 -6645 -6966
    Issuance (Retirement) of Stock, Net -10552 -3004 -2094 -5332 -1336
    Issuance (Retirement) of Debt, Net -2559 -5986 7072 -4957 4177
    Foreign Exchange Effects -32 -266 286 69 -26
    Net Change in Cash -4890 2749 -1454 -2159 4411
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 2294 6955 5489 3914 2219
    Cash From Operating Activities 2957 14236 10125 5404 1649
    Cash From Operating Activities 377 7181 5233 3207 1405
    Amortization 1619
    Non-Cash Items 1085 4404 3417 2164 918
    Cash Taxes Paid 348 1975 1559 1239 633
    Cash Interest Paid 123 696 475 308 110
    Changes in Working Capital -2418 -4304 -4014 -3881 -2893
    Cash From Investing Activities 10621 1468 2935 -2263 9365
    Capital Expenditures -470 -2671 -2024 -1442 -859
    Other Investing Cash Flow Items, Total 11091 4139 4959 -821 10224
    Cash From Financing Activities -9202 -20562 -16568 -11830 -9528
    Financing Cash Flow Items -169 55 99 97 22
    Total Cash Dividends Paid -7255 -7506 -7506 -7506 -7506
    Issuance (Retirement) of Stock, Net -2727 -10552 -7874 -5156 -2448
    Issuance (Retirement) of Debt, Net 949 -2559 -1287 735 404
    Foreign Exchange Effects 107 -32 -173 -93 -41
    Net Change in Cash 4483 -4890 -3681 -8782 1445
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    BlackRock Institutional Trust Company, N.A. Investment Advisor 5.3489 121820582 0 2022-12-31 LOW
    Sandoz Family Other Insider Investor 3.9138 89135960 0 2022-12-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.7121 61766714 296752 2023-07-31 LOW
    UBS Asset Management (Switzerland) Investment Advisor 2.4548 55906821 176139 2022-12-31 LOW
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.3806 54217976 0 2022-12-31 LOW
    Credit Suisse Asset Management Investment Advisor/Hedge Fund 2.1663 49335879 -677105 2022-12-31 LOW
    Wellington Management Company, LLP Investment Advisor/Hedge Fund 1.9274 43897216 21743 2023-07-31 LOW
    Zürcher Kantonalbank (Asset Management) Bank and Trust 1.1612 26446726 118560 2023-07-31 LOW
    BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.8719 19856757 66327 2023-07-31 LOW
    Artisan Partners Limited Partnership Investment Advisor 0.7614 17341049 362533 2023-06-30 LOW
    Dodge & Cox Investment Advisor/Hedge Fund 0.7467 17006670 -3098900 2023-06-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5902 13441576 3568 2023-07-31 LOW
    Capital Research Global Investors Investment Advisor 0.5743 13079359 -7484 2023-06-30 LOW
    DWS Investment GmbH Investment Advisor/Hedge Fund 0.5467 12450739 284839 2023-07-31 LOW
    Pictet Asset Management Ltd. Investment Advisor/Hedge Fund 0.5323 12122921 37703 2023-04-30 LOW
    California Public Employees' Retirement System Pension Fund 0.5222 11892523 2527466 2022-06-30 LOW
    Nuveen LLC Pension Fund 0.3751 8543005 47653 2023-07-31 LOW
    MFS Investment Management Investment Advisor/Hedge Fund 0.3554 8095235 -17005 2023-06-30 LOW
    BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.3527 8032113 3765 2023-05-31 LOW
    Amundi Asset Management, SAS Investment Advisor/Hedge Fund 0.2998 6828283 -276205 2023-07-31 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Novartis - CHF Company profile

    Novartis AG (NVS) is a global pharmaceutical company.  Founded in 1996 through a merger of Ciba-Geigy and Sandoz, Novartis is headquartered in Basel, Switzerland. The firm has two divisions: Innovative Medicines and Sandoz.

    Innovative Medicines offer prescription medicines and create treatments in areas of respiratory, ophthalmology, neuroscience, immunology, hepatology, dermatology, cardiovascular, renal and metabolism. 

    Sandoz develops, manufactures and markets generic pharmaceuticals and biosimilars. Sandoz products include: Adakveo (crizanlizumab), Afinitor Disperz/Votubia (everolimus) and Arzerra (ofatumumab) for Oncology; and Aimovig (erenumab) for neuroscience. 

    In 2020, in response to the pandemic, the company collaborated with Molecular Partners to develop ensovibep, a DARPin therapeutic candidate designed for potential use against Covid-19. 

    The company’s shares have been listed on the New York Stock Exchange (NYSE) since 2000. Novartis AG stock is traded under the ticker symbol NVS. You can track live NVS share value and price history at Capital.com.

    Industry: Pharmaceuticals (NEC)

    Lichtstrasse 35
    BASEL
    BASEL-STADT 4056
    CH

    Income Statement

    • Annual
    • Quarterly

    News

    EUR/USD tests key support

    EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

    14:32, 21 September 2023
    Bank of England building

    BoE leaves rates unchanged, GBP drops further as investors look for more clarity

    The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

    11:45, 21 September 2023
    British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

    GBP softer after CPI surprise, JPY focused on any further hints from Ueda

    GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

    12:42, 20 September 2023

    How to Trade The Break & Retest

    In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

    11:59, 20 September 2023

    Cable coils near lows ahead of Fed and BoE rate decisions

    It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.

    14:16, 19 September 2023

    FTSE 100 Technical Outlook - 18 September 2023

    In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.

    06:55, 19 September 2023
    View of the City of London’s illuminated financial district skyline at dusk

    Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally

    The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.

    13:46, 15 September 2023

    People also watch

    XRP/USD

    0.51 Price
    -0.240% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.01192

    BTC/USD

    26,617.40 Price
    -0.080% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 85.00

    Oil - Crude

    90.14 Price
    +0.770% 1D Chg, %
    Long position overnight fee 0.0415%
    Short position overnight fee -0.0634%
    Overnight fee time 21:00 (UTC)
    Spread 0.030

    ETH/USD

    1,595.12 Price
    -0.070% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 5.40

    Still looking for a broker you can trust?

    Join the 555.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading